📰 Device Designations News
Page 3 - Device Designations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Designations. Real-time updates on events, politics, business and more.
July 7, 2023
PRINCETON, N.J., July 07, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its...
July 7, 2023
PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its
June 15, 2023
PRINCETON, N.J., June 15, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its... | June 15, 2023
April 20, 2023
PRINCETON, N.J., April 20, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via... | April 20, 2023
April 19, 2023
PRINCETON, N.J., April 19, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via... | April 19, 2023
March 29, 2023
PRINCETON, N.J., March 29, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood... | March 29, 2023
February 27, 2023
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
February 24, 2023
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
February 23, 2023
The company has now been awarded a total of eight FDA Breakthrough Device Designations for its innovative SCI therapiesEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023
February 1, 2023
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue - read this article along with other careers information, tips and advice on BioSpace